black-cbo-cancer-chrna-report.pdf
Key All Cancer CHRNA participants All Black American participants Afro-Caribbean participants Afro-Caribbean ...
Black Men Are at Increased Risk for Prostate Cancer
Dr. Joseph E. Ravenell, a public health expert at NYU Langone’s Perlmutter Cancer Center, discusses prostate cancer risk factors for Black men.
Blink Assessment Essential for Face Transplants
A retrospective research study concludes that careful blink assessment is essential in facial transplantation procedures in order to ensure optimal long-term vision for transplant recipients.
Blocking Key Protein Triggers Cancer Cell Self-Destruction
NYU Langone researchers found that a type of cell death caused by a buildup of highly reactive molecules suppresses lung tumor growth.
Blood & Marrow Transplant Program Expands Services
NYU Langone’s Blood and Marrow Transplant Program expands services and receives accreditation for adult allogeneic transplants.
Blood Cancer Pilot Grants Support Translational Research
Pilot grant funding from the Center for Blood Cancers, part of NYU Langone’s Perlmutter Cancer Center, aims to spur new ideas for treatment.
Blood Plasma May Hold the Key to Treating COVID-19
NYU Langone researchers are looking at blood plasma from people who have recovered from COVID-19 as a potential treatment for the virus.
Blood Pressure Drugs Work Against Deadly Malaria Symptom
A study at NYU Langone found that adding a blood pressure medication to the standard drug used to treat malaria may reduce bleeding deaths.
Blood Pressure Medications Are Safe for People with COVID-19
NYU Langone researchers have found that high blood pressure medications did not increase the risk of COVID-19 contraction or complications.
Blood Pressure Medications Safe for People with COVID-19
NYU Langone cardiologist Dr. Harmony R. Reynolds’s research shows blood pressure medications did not increase the risk of COVID-19 infection.